161 related articles for article (PubMed ID: 22080846)
1. Neutropenia after rituximab treatment: new insights on a late complication.
Wolach O; Shpilberg O; Lahav M
Curr Opin Hematol; 2012 Jan; 19(1):32-8. PubMed ID: 22080846
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-induced late-onset neutropenia in newly diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism.
Li SC; Chen YC; Evens AM; Lee CC; Liao HF; Yu CC; Tung YT; Su YC
Am J Hematol; 2010 Oct; 85(10):810-2. PubMed ID: 20730791
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center.
Besada E; Koldingsnes W; Nossent J
QJM; 2012 Jun; 105(6):545-50. PubMed ID: 22301823
[TBL] [Abstract][Full Text] [Related]
4. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.
Wolach O; Bairey O; Lahav M
Medicine (Baltimore); 2010 Sep; 89(5):308-318. PubMed ID: 20827108
[TBL] [Abstract][Full Text] [Related]
5. Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.
Tesfa D; Palmblad J
Expert Rev Hematol; 2011 Dec; 4(6):619-25. PubMed ID: 22077526
[TBL] [Abstract][Full Text] [Related]
6. Neutropenia associated with rituximab therapy.
Grant C; Wilson WH; Dunleavy K
Curr Opin Hematol; 2011 Jan; 18(1):49-54. PubMed ID: 21102324
[TBL] [Abstract][Full Text] [Related]
7. Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study.
Ishida H; Inui M; Furusawa M; Tanabe K
Transpl Immunol; 2013 Mar; 28(2-3):93-9. PubMed ID: 23353568
[TBL] [Abstract][Full Text] [Related]
8. [Late-onset neutropenia following rituximab therapy as a treatment of diffuse large B-cell lymphoma: a single institution study].
Kim M; Lee JK; Hong YJ; Hong SI; Kang HJ; Chang YH
Korean J Lab Med; 2010 Dec; 30(6):575-9. PubMed ID: 21157141
[TBL] [Abstract][Full Text] [Related]
9. A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study.
Nitta E; Izutsu K; Sato T; Ota Y; Takeuchi K; Kamijo A; Takahashi K; Oshima K; Kanda Y; Chiba S; Motokura T; Kurokawa M
Ann Oncol; 2007 Feb; 18(2):364-9. PubMed ID: 17079695
[TBL] [Abstract][Full Text] [Related]
10. Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.
Tesfa D; Ajeganova S; Hägglund H; Sander B; Fadeel B; Hafström I; Palmblad J
Arthritis Rheum; 2011 Aug; 63(8):2209-14. PubMed ID: 21560117
[TBL] [Abstract][Full Text] [Related]
11. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.
Terrier B; Ittah M; Tourneur L; Louache F; Soumelis V; Lavie F; Casadevall N; Candon S; Hummel A; Mariette X; Buzyn A
Haematologica; 2007 Feb; 92(2):e20-3. PubMed ID: 17405749
[TBL] [Abstract][Full Text] [Related]
12. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
Lai GG; Lim ST; Tao M; Chan A; Li H; Quek R
Am J Hematol; 2009 Jul; 84(7):414-7. PubMed ID: 19415727
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Zonozi R; Wallace ZS; Laliberte K; Huizenga NR; Rosenthal JM; Rhee EP; Cortazar FB; Niles JL
Arthritis Rheumatol; 2021 Feb; 73(2):347-354. PubMed ID: 32892495
[TBL] [Abstract][Full Text] [Related]
14. Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma.
Aguiar-Bujanda D; Blanco-Sánchez MJ; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura-Grau S; Bohn-Sarmiento U
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):761-5. PubMed ID: 26319620
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.
Weng WK; Negrin RS; Lavori P; Horning SJ
J Clin Oncol; 2010 Jan; 28(2):279-84. PubMed ID: 19933905
[TBL] [Abstract][Full Text] [Related]
16. Late onset neutropenia after rituximab and obinutuzumab treatment - characteristics of a class-effect toxicity.
Shimony S; Bar-Sever E; Berger T; Itchaki G; Gurion R; Yeshurun M; Lahav M; Raanani P; Wolach O
Leuk Lymphoma; 2021 Dec; 62(12):2921-2927. PubMed ID: 34284690
[TBL] [Abstract][Full Text] [Related]
17. Late-onset neutropenia following rituximab treatment for rheumatologic conditions.
Breuer GS; Ehrenfeld M; Rosner I; Balbir-Gurman A; Zisman D; Oren S; Paran D
Clin Rheumatol; 2014 Sep; 33(9):1337-40. PubMed ID: 24599679
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma.
Arai Y; Yamashita K; Mizugishi K; Nishikori M; Hishizawa M; Kondo T; Kitano T; Kawabata H; Kadowaki N; Takaori-Kondo A
Hematology; 2015 May; 20(4):196-202. PubMed ID: 25130775
[TBL] [Abstract][Full Text] [Related]
19. Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Auer M; Bsteh G; Hegen H; Wurth S; Zinganell A; Berger T; Deisenhammer F; Pauli FD
Mult Scler Relat Disord; 2020 Aug; 43():102155. PubMed ID: 32470856
[TBL] [Abstract][Full Text] [Related]
20. Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.
Ajeganova S; Tesfa D; Hägglund H; Fadeel B; Vedin I; Zignego AL; Palmblad J
Arthritis Res Ther; 2017 Mar; 19(1):44. PubMed ID: 28270182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
